跳至主要内容
临床试验/CTRI/2018/08/015157
CTRI/2018/08/015157已完成未知

A randomised, double blind placebo controlled trial to evaluate theantioxidant and rejuvenation potential of full spectrum extract ofAMLA in adults.

Acara Bioherb Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients of either sex, 20 to 60 years of age
  • Patients with BMI range 20 to 34 kg/m2
  • Patients with diabetes, obesity and hyper-lipidemia as co-morbid conditions.
  • NAFLD patients who are refractive to standard drugs of treatment (statins).
  • Willing to come for regular follow -up visits.
  • Able to give written informed consent.

排除标准

  • Known history of hypersensitivity to herbal extracts or dietary supplements.
  • Duration of jaundice greater than 3 months, steato-hepatitis, advanced fibrosis, cirrhosis, viral hepatitis and other liver diseases.
  • Pregnant women, lactating women and women of child bearing potential not following adequate contraceptive measure, women who were found positive for urine pregnancy test.
  • Patients who are on immuno-modulatory drugs.
  • Ongoing treatment with herbals or allopathic hepato-protective drugs.
  • Patients on coronary artery disease.
  • Evidence of several renal, hepatic or hemopoitic disease or severe cardiac insufficiency as revealed by laboratory investigations.

研究者

发起方
Acara Bioherb Pvt Ltd

相似试验

A study of AMLA extract to assess the antioxidant... | 临床试验